8 May, 12-1pm, Seminar room 1, TRF
Professor
Marcel Nold
Research Group Head,
Interventional Immunology in Neonatal Diseases
Inflammation is now recognised as the main
pathogenetic culprit in many of the major diseases that affect infants born prematurely,
for example illnesses of heart and lung such as bronchopulmonary dysplasia and
pulmonary hypertension, and of the intestine such as necrotising enterocolitis.
These diseases cause not only acute morbidity and mortality, but commonly also
severe long-term sequelae. However, the immunological processes that underlie
these diseases are surprisingly poorly characterised, with the result that
clinicians have no preventative approaches or effective treatments. Our
research aims to address the resulting urgent unmet medical need by deriving
novel treatment strategies from our exploration of the virtually unmapped
frontier of neonatal immunology.
Professor
Marcel F Nold is a clinician-scientist, paediatrician and neonatologist. His
work, carried out in Germany, the USA and lately in Australia, is focussed on
interventional immunology and has attracted the interest of opinion-leading
journals and pharmaceutical companies. Marcel is passionate about his research
making a meaningful difference to his baby patients and their families.
Therefore, aiming to lay the foundations for much-needed new therapies, Marcel
employs bedside-to-bench-and-back approaches to explore the molecular
mechanisms underpinning severe diseases of premature infants, such as
bronchopulmonary dysplasia, pulmonary hypertension and necrotising
enterocolitis.
No comments:
Post a Comment